NASDAQ:CPIX Cumberland Pharmaceuticals (CPIX) Stock Forecast, Price & News $1.58 -0.02 (-0.94%) (As of 05/26/2023 04:00 PM ET) Add Compare Share Share Today's Range$1.58▼$1.6350-Day Range$1.59▼$2.0152-Week Range$1.55▼$2.91Volume16,700 shsAverage Volume21,846 shsMarket Capitalization$22.90 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media About Cumberland Pharmaceuticals (NASDAQ:CPIX) StockCumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its products include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, Sancuso, Boxaban, Vasculan. Dyscorban, and RediTrex. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN.Read More Receive CPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CPIX Stock News HeadlinesMay 29, 2023 | msn.comTeen dies after car drives into water at Lake CumberlandMay 28, 2023 | msn.comCumberland County asks for help identifying driver of a white, four-door Crown Victoria, last seen near Chickenfoot RoadMay 30, 2023 | Edge On The Street (Ad)How to Invest in AI's Fast-Growing MarketThe AI market stands at $160 billion in 2023. Estimates are the AI market will grow 20-fold to $1.8 TRILLION by 2030. One little-known company is looking to win big with a new network technology no one else has. AI could explode... and soon.May 27, 2023 | msn.comTeenager drowns after vehicle enters Lake CumberlandMay 27, 2023 | msn.comMissing boy out of Cumberland County, KY, found safeMay 27, 2023 | msn.comTeenager pronounced dead at Lake CumberlandMay 27, 2023 | news.yahoo.comTeen pronounced dead after vehicle goes into water at Lake Cumberland boat rampMay 27, 2023 | msn.comSearch for missing boy underway in Cumberland County, KYMay 30, 2023 | Edge On The Street (Ad)How to Invest in AI's Fast-Growing MarketThe AI market stands at $160 billion in 2023. Estimates are the AI market will grow 20-fold to $1.8 TRILLION by 2030. One little-known company is looking to win big with a new network technology no one else has. AI could explode... and soon.May 26, 2023 | msn.comCumberland County police charge man with aggravated assault, robbery of wheelchair-bound victimMay 26, 2023 | msn.comA guide to camping on Cumberland IslandMay 26, 2023 | msn.comCumberland County father facing charges for death of 13-month-old childMay 26, 2023 | americanbankingnews.comCumberland Pharmaceuticals (NASDAQ:CPIX) Earns Hold Rating from Analysts at StockNews.comMay 26, 2023 | msn.comWilson defeats Cumberland Valley in District 3 Class 3A girls lacrosse quarterfinalMay 25, 2023 | msn.comCumberland County woman to appear on ‘Jeopardy!’May 25, 2023 | msn.comNew Cumberland cemetery prepares for Memorial DayMay 25, 2023 | msn.comNothing Bundt Cakes to hold grand opening in Cumberland CountyMay 25, 2023 | msn.comOfficials propose defunding 48 positions in the Cumberland County JailMay 25, 2023 | msn.comCumberland County man to serve up to 18 years in prison following his 7th drug dealing convictionMay 24, 2023 | nj.comMillville’s Gilson, Woodstown’s Schermerhorn win titles at Salem/Cumberland golf tourneyMay 24, 2023 | sports.yahoo.comCumberland woman indicted on drug distribution chargesMay 24, 2023 | msn.comCumberland County home ‘is not livable’ after fireMay 24, 2023 | msn.comCumberland County woman to appear on Jeopardy!May 23, 2023 | finance.yahoo.comCUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR NEW TREATMENT OF IDIOPATHIC PULMONARY FIBROSISMay 19, 2023 | americanbankingnews.comCumberland Pharmaceuticals (NASDAQ:CPIX) Research Coverage Started at StockNews.comMay 16, 2023 | msn.comWellSpan Health announces plans to build 3 new neighborhood hospitals to serve Cumberland, York countiesMay 16, 2023 | msn.comWellSpan plans to build 3 new community hospitals in York and Cumberland countiesSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CPIX Company Calendar Last Earnings3/07/2023Today5/29/2023Next Earnings (Estimated)8/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals SectorMedical Current SymbolNASDAQ:CPIX CUSIP23077010 CIK1087294 Webwww.cumberlandpharma.com Phone(615) 255-0068Fax615-255-0094Employees83Year Founded1999Profitability EPS (Most Recent Fiscal Year)($0.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,570,000.00 Net Margins-9.97% Pretax Margin-10.00% Return on Equity4.76% Return on Assets1.95% Debt Debt-to-Equity Ratio0.45 Current Ratio1.70 Quick Ratio1.31 Sales & Book Value Annual Sales$42.01 million Price / Sales0.55 Cash Flow$0.47 per share Price / Cash Flow3.35 Book Value$2.45 per share Price / Book0.65Miscellaneous Outstanding Shares14,450,000Free Float8,370,000Market Cap$22.90 million OptionableOptionable Beta0.34 Social Links Key ExecutivesA. J. KazimiChairman & Chief Executive OfficerJohn M. HammChief Financial & Accounting OfficerJames L. HermanChief Compliance Officer & Senior Vice PresidentTodd AnthonyExecutive Director-Organizational DevelopmentAdam S. MostafaManaging DirectorKey CompetitorsAssembly BiosciencesNASDAQ:ASMBAngion BiomedicaNASDAQ:ANGNOnconova TherapeuticsNASDAQ:ONTXCocrystal PharmaNASDAQ:COCPImmix BiopharmaNASDAQ:IMMXView All CompetitorsInsiders & InstitutionsDimensional Fund Advisors LPSold 14,838 shares on 5/12/2023Ownership: 4.229%Renaissance Technologies LLCSold 10,300 shares on 5/12/2023Ownership: 3.970%BlackRock Inc.Sold 8,682 shares on 5/12/2023Ownership: 0.916%James JonesBought 88 shares on 12/21/2022Total: $195.36 ($2.22/share)Caroline YoungBought 30 shares on 12/19/2022Total: $66.30 ($2.21/share)View All Insider TransactionsView All Institutional Transactions CPIX Stock - Frequently Asked Questions How have CPIX shares performed in 2023? Cumberland Pharmaceuticals' stock was trading at $2.25 at the start of the year. Since then, CPIX shares have decreased by 29.6% and is now trading at $1.5850. View the best growth stocks for 2023 here. When is Cumberland Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023. View our CPIX earnings forecast. How were Cumberland Pharmaceuticals' earnings last quarter? Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced its quarterly earnings results on Tuesday, March, 7th. The specialty pharmaceutical company reported ($0.06) earnings per share (EPS) for the quarter. The specialty pharmaceutical company earned $9.12 million during the quarter. Cumberland Pharmaceuticals had a negative net margin of 9.97% and a positive trailing twelve-month return on equity of 4.76%. What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO? 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Cumberland Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS). What is Cumberland Pharmaceuticals' stock symbol? Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX." Who are Cumberland Pharmaceuticals' major shareholders? Cumberland Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (4.23%), Renaissance Technologies LLC (3.97%) and BlackRock Inc. (0.92%). Insiders that own company stock include A J Kazimi, A J Kazimi, Caroline Young, James Jones, Joseph C Galante, Kenneth Krogulski, Martin E Cearnal, Martin E Cearnal and William Sumas. View institutional ownership trends. How do I buy shares of Cumberland Pharmaceuticals? Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cumberland Pharmaceuticals' stock price today? One share of CPIX stock can currently be purchased for approximately $1.59. How much money does Cumberland Pharmaceuticals make? Cumberland Pharmaceuticals (NASDAQ:CPIX) has a market capitalization of $22.90 million and generates $42.01 million in revenue each year. The specialty pharmaceutical company earns $-5,570,000.00 in net income (profit) each year or ($0.28) on an earnings per share basis. How can I contact Cumberland Pharmaceuticals? Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The official website for the company is www.cumberlandpharma.com. The specialty pharmaceutical company can be reached via phone at (615) 255-0068, via email at investors@cumberlandpharma.com, or via fax at 615-255-0094. This page (NASDAQ:CPIX) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.